- Report
- January 2024
- 120 Pages
Global
From €7199EUR$7,950USD£6,141GBP
- Drug Pipelines
- January 2024
- 136 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- January 2024
- 160 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- January 2024
- 395 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- January 2024
- 250 Pages
Global
From €7199EUR$7,950USD£6,141GBP
- Report
- January 2024
- 120 Pages
Global
From €7199EUR$7,950USD£6,141GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2490EUR$2,750USD£2,124GBP
- Report
- November 2023
- 92 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- August 2023
- 76 Pages
Global
From €3577EUR$3,950USD£3,051GBP
- Report
- August 2023
- 166 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- August 2023
- 80 Pages
Global
From €3577EUR$3,950USD£3,051GBP
- Report
- August 2023
- 217 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- August 2023
- 102 Pages
Global
From €4301EUR$4,750USD£3,669GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2490EUR$2,750USD£2,124GBP
- Report
- July 2023
- 128 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- July 2023
- 135 Pages
Global
From €6791EUR$7,500USD£5,793GBP
- Report
- July 2023
- 64 Pages
Global
From €3577EUR$3,950USD£3,051GBP
- Report
- April 2023
- 121 Pages
Global
From €3577EUR$3,950USD£3,051GBP
- Report
- April 2023
- 140 Pages
Global
From €8602EUR$9,500USD£7,338GBP
- Report
- April 2023
- 164 Pages
Global
From €8602EUR$9,500USD£7,338GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more